Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Drug Discovery & Development
Return to: PBR Home | Drug Research | Drug Discovery & Development
Search Refinements
Search Results: Drug Discovery & Development
1-15 of 5210 results
Cumberland Pharmaceuticals unveils new program to develop Vasculan for systemic sclerosis
Cumberland Pharmaceuticals has unveiled a new program to develop Vasculan for systemic sclerosis.
Drug Research > Drug Discovery & Development > News
X-Chem achieves milestone in drug discovery collaboration with Alexion Pharmaceuticals
X-Chem has achieved a milestone in its drug discovery collaboration with Alexion Pharmaceuticals, triggering a payment to X-Chem.
Drug Research > Drug Discovery & Development > News
Zymeworks, GSK enter second collaboration to develop bi-specific antibodies
Zymeworks has entered into a new licensing agreement with GSK for the research, development, and commercialization of novel bi-specific antibodies enabled using Zymeworks’ Azymetric drug discovery platform.
Drug Research > Drug Discovery & Development > News
NewLink Genetics wins $21.6m contract option from BARDA for Ebola vaccine development
NewLink Genetics announced that the Biomedical Advanced Research and Development Authority (BARDA) of the United States Department of Health and Human Services (HHS) has exercised its $21.6m option to support continued development of the investigational rVSV-ZEBOV-GP (Ebola) vaccine candidate.
Drug Research > Drug Discovery & Development > News
hVIVO, SEEK to work together to develop vaccines against Flu and Zika infections
By PBR Staff Writer
hVIVO has unveiled a joint venture (JV) investment with the SEEK Group for the development of vaccines against influenza and mosquito-borne diseases like the Zika virus and other flaviviruses.
Drug Research > Drug Discovery & Development > News
AstraZeneca launches genomics initiative to transform drug discovery and development
By PBR Staff Writer
AstraZeneca has launched a new initiative to screen around two million genomes sequences for information that will guide in advancing drug discovery and development across its research and development platforms.
Drug Research > Drug Discovery & Development > News
Aptuit acquires Exquiron Biotech
Aptuit has acquired Exquiron Biotech to meet customer demand for fully integrated outsourced discovery services.
Drug Research > Drug Discovery & Development > News
SBP, GSK create new center for translational neuroscience
Sanford Burnham Prebys Medical Discovery Institute (SBP) and GlaxoSmithKline (GSK) have created the SBP-GSK Center for Translational Neuroscience.
Drug Research > Drug Discovery & Development > News
Yabao Pharmaceutical, Salus Pharma partner to develop generic drugs
Yabao Pharmaceutical and Salus Pharma have announced a strategic partnership to co-develop, manufacture and commercialize high technological barrier generic drugs worldwide.
Drug Research > Drug Discovery & Development > News
Second Genome secures $42.6m funding to expand microbiome discovery platform
Second Genome, a privately-held biopharmaceutical company developing novel medicines through innovative microbiome science, has closed an oversubscribed Series B investment round with $42.6m in financing.
Drug Research > Drug Discovery & Development > News
DalCor completes $150m financing to continue development of dalcetrapib in ACS
By PBR Staff Writer
DalCor Pharmaceuticals has wrapped up a private financing round valued at $150m to continue the development of dalcetrapib in genetically distinct patients with acute coronary syndrome (ACS).
Drug Research > Drug Discovery & Development > News
NanoAntibiotics acquires biotechnology firm LAT Pharma
NanoAntibiotics has acquired LAT Pharma LLC, of Chicago, IL, an early-stage biotechnology company developing novel medicines to treat life-threatening complications of liver cirrhosis.
Drug Research > Drug Discovery & Development > News
Sunny Pharmtech and Vitruvias partner to co-develop several high value generic drugs
Sunny Pharmtech and Vitruvias Therapeutics have signed two additional agreements to co-develop and market two additional high-value generic drugs.
Drug Research > Drug Discovery & Development > News
Heptares, Kymab partner to develop novel antibody therapeutics
By PBR Staff Writer
Heptares Therapeutics and Kymab have partnered to discover, develop and commercialize novel antibody therapeutics.
Drug Research > Drug Discovery & Development > News
WuXi AppTec acquires Crelux to improve structure-based drug discovery capabilities
WuXi AppTec has acquired Crelux, a structure based drug discovery provider based in Munich, Germany
Drug Research > Drug Discovery & Development > News

PBR Supplier Recommendations

LABORATORIOS INIBSA - Pharmaceutical Contract Manufacturing Company
LABORATORIOS INIBSA is a pharmaceutical contract manufacturing company. We have more than 60 years' experience and belong to the INIBSA GROUP. INIBISA supplies products and services to Biotools, Inibsa Dental and Inibsa Hospital, as well as other pharmaceutical companies through our contract manufacturing division. From our facilities in Lliçà de Vall, 20km from Barcelona LABORATORIOS INIBSA currently supplies more than 50 countries worldwide.... Drug Research > Drug Discovery & Development > Suppliers
Chemoswed - Suppliers of Active Pharmaceutical Ingredients
Chemoswed is the reliable Swedish custom synthesis specialist, supplying active ingredients since 1944. With a background in Pharmacia, Chemoswed is since 1996 an independent entity within the DuPont group, offering cost-effective, turn-key solutions to API needs worldwide.We have established unparalleled experience and technology, enabling efficient development and production of quality active pharmaceutical ingredients in quantities from 100 grams to 50 tons.... Drug Research > Drug Discovery & Development > Suppliers
Novo Nordisk Pharmatech A/S - Insulin Human and Benzalkonium Chloride Products
Novo Nordisk Pharmatech A/S is a Novo Nordisk company that specialises in the supply of ingredients for the biopharmaceutical and pharmaceutical industries, such as insulin human for cell culture media and cGMP manufactured quaternary ammonium compounds (usually referred to as quats) such as benzalkonium chloride, cetrimide and cetrimonium bromide.... Drug Research > Drug Discovery & Development > Suppliers
Biovian - cGMP Contract Manufacturing of Biopharmaceuticals
Biovian is a dynamic and effective new generation one-stop-shop CMO in cGMP contract manufacturing of biopharmaceuticals. Biovian's services cover the full range from antigen isolation, expression, vector construction, cell line cultivation, cGMP protein purification to product fill and finish.... Drug Research > Drug Discovery & Development > Suppliers
Tosoh Bioscience - Your Specialist in Separation
Tosoh Bioscience is an acknowledged global leader in the field of liquid chromatography with a strong focus on bioseparations. We offer solutions for research, drug discovery, clinical chemistry, environmental analysis, manufacturing and other industrial applications. ... Drug Research > Drug Discovery & Development > Suppliers
See more

PBR White Paper Recommendations

1.5 Specific dsDNA Quantification UV/VIS-based cDrop™ Method vs Picogreen® Fluorescent Assay By Trinean
Precise quantification and normalization of isolated genomic DNA is critical for advanced molecular testing in life science research and molecular diagnostics. UV-Vis based quantification has long been the method of choice, mainly because of its convenience. However, determining the DNA concentration based on the absorbance at 260nm suffers from interference of components such as RNA, proteins and phenols. Alternative methods, such as the PicoGreen® based Quant-iT™ assay, based on fluorescence enhancement upon binding with dsDNA have been developed to address this issue.... Drug Research > Drug Discovery & Development > White Papers 1.3 Micro-volume Protein Quantification using the DropSense96 Droplet Plate Reader By Trinean
The measurement of protein concentration in aqueous samples is an important assay in biochemistry research and protein production facilities. Spectrophotometric protein quantification assays are commonly used methods to rapidly determine the concentration of a protein. They utilize the direct UV absorbance of the protein at 280nm in combination with its extinction coefficient or an indirect dye-based methods like BCA, Lowry and Bradford assays.... Drug Research > Drug Discovery & Development > White Papers 1.2 DropSense96 and its DropPlates, a Versatile Tool for Nucleic Acid and Protein Droplet Quantification By Trinean
As the demand for molecular tests increases, automated systems for biomolecule isolation and sample analysis are becoming popular. These facilitate integration of the complete molecular test in a full automatic set-up with liquid robots and bar-coded sample tracking resulting in a significant higher throughput while minimizing tedious manual repetitive tasks. The Trinean technology is a unique combination of the DropSense96 droplet plate reader, the 96well DropPlate microfuidic consumables and the DropQuant analytical software enabling direct quantification of small biomolecule samples in these high throughput, automated workflow.... Drug Research > Drug Discovery & Development > White Papers 1.14 Droplet UV/VIS Quantification of Native Proteins in Biopharmaceutical Processing By Trinean
Biopharmaceuticals are mainly produced by microbial fermentation or in animal cell cultures. As a consequence, a cascade of procedures including purification and characterization are required throughout the processing chain to obtain the protein at the desired level of purity and potency. Within these processes, quantification of the protein of interest is mandatory at critical steps to maintain confidence in the processing results and fidelity in the end product.... Drug Research > Drug Discovery & Development > White Papers 1.20 Quantification of His-tagged IgG antibodies after IMAC Ni-column purification By Trinean
Trinean introduces a new cDrop™ application suited for the quantification (OD280) of IgG antibodies and derivatives like Fab fragments during purification by IMAC Ni-columns using imidazole-containing buffers.... Drug Research > Drug Discovery & Development > White Papers See more
1-15 of 5210 results